We will study the metabolism and action of methyl-n-amylnitrosamine (MNAN) in the esophagus as follows: (1) We will examine the production of hydroxy and keto metabolites of MNAN in freshly removed esophagus, forestomach and other tissues of rodents. We will complete studies of changes with age of this metabolism in key tissues of suckling rats and hamsters, determine whether these changes are due to intrinsic or extrinsic factors, examine effects of agents that induce individual P-450s, and determine configurations of the hydroxy-MNAN metabolites. (2) We will develop systems for culturing adult rat esophagus, while still maintaining MNAN metabolism. We will study MNAN metabolism in cultures of newborn and adult rat forestomach, hamster forestomach and hamster esophagus, and by freshly incubated adult and fetal human esophagus, and study effects of inducers and other agents on these cultures. (3) We will examine MNAN metabolism by rat liver and esophageal microsomes and reconstituted cytochrome P-450 (""""""""P-450"""""""") systems to determine which P-450s metabolize MNAN. Gel electrophoresis and specific antibodies will identify the individual P-450s in adult and developed esophagus and forestomach. (4) We will examine MNAN alkylation of DNA to give 06- and N7 alkylguanine and 04-alkylthymine, using 3H-MNAN or radioimmunoassay. In vivo persistence of alkylated bases in esophageal DNA will be measured, and DNA alkylation by 2- and 4-oxo-MNAN. (5) We will determine whether MNAN is taken up more extensively than dimethylnitrosamine by rat esophagus. (6) We will compare carcinogenicity of MNAN injected into newborn, 3-day-old and adult rats and hamsters, test for carcinogenicity of 2- and 4-oxo-MNAN in adult rats, and determine whether inducers can affect MNAN carcinogenicity. These studies are designed to investigate (a) why MNAN is a specific carcinogen for the rat esophagus, (b) what intrinsic or extrinsic factors control the striking changes in MNAN metabolism from newborn to adult rats and hamsters, and (c) whether human esophagus could be susceptible to nitrosamine carcinogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA035628-07
Application #
3173218
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1983-09-01
Project End
1992-02-29
Budget Start
1990-03-01
Budget End
1992-02-29
Support Year
7
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Zhou, Lin; Mirvish, Sidney S (2005) Inhibition by allyl sulfides and crushed garlic of O6-methylguanine formation in liver DNA of dimethylnitrosamine-treated rats. Nutr Cancer 51:68-77
Morris, Chantey R; Chen, Sheng C; Zhou, Lin et al. (2004) Inhibition by allyl sulfides and phenethyl isothiocyanate of methyl-n-pentylnitrosamine depentylation by rat esophageal microsomes, human and rat CYP2E1, and Rat CYP2A3. Nutr Cancer 48:54-63
Chen, S C; Zhou, L; Ding, X et al. (2001) Depentylation of the rat esophageal carcinogen, methyl-n-pentylnitrosamine, by microsomes from various human and rat tissues and by cytochrome P450 2A3. Drug Metab Dispos 29:1221-8
Morris, C R; Chen, S C; Hinman, C et al. (2000) Inhibition of methyl-n-amylnitrosamine hydroxylation by diallyl sulfide and phenethylisothiocyanate in the rat. Nutr Cancer 37:199-206
Haorah, J; Miller, D W; Brand, R et al. (1999) Diffusion of dialkylnitrosamines into the rat esophagus as a factor in esophageal carcinogenesis. Carcinogenesis 20:825-36
Chen, S C; Wang, X; Xu, G et al. (1999) Depentylation of [3H-pentyl]methyl-n-amylnitrosamine by rat esophageal and liver microsomes and by rat and human cytochrome P450 isoforms. Cancer Res 59:91-8
Mirvish, S S (1997) Studies on experimental animals involving surgical procedures and/or nitrosamine treatment related to the etiology of esophageal adenocarcinoma. Cancer Lett 117:161-74
Mirvish, S S; Nickols, J; Weisenburger, D D et al. (1996) Carcinogenicity tests of methyl-n-amylnitrosamine (MNAN) administered to newborn and adult rats and hamsters and adult mice and of 2-oxo-MNAN administered to adult rats. Cancer Lett 107:171-7
Schneider, P; Hinrichs, S; Zulim, R et al. (1996) Carcinogenesis by methylbenzylnitrosamine near the squamocolumnar junction and methylamylnitrosamine metabolism in the mouse forestomach. Cancer Lett 102:125-31
Mirvish, S S (1995) Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 93:17-48

Showing the most recent 10 out of 28 publications